Doubt Cast on Major Role for PFO Closure in Cryptogenic Stroke
March 1, 2011|Internal Medicine News
Author and Disclosure Information
FROM THE ANNUAL SCIENTIFIC SESSIONS OF THE AMERICAN HEART ASSOCIATION
The CLOSURE I study was sponsored by NMT Medical, which markets the STARFlex closure device. Dr. Furlan said that he is a consultant to NMT Medical and was the principal investigator for the trial. Dr. Amarenco said that he has received research grants from Sanofi-Aventis, Bristol-Myers Squibb, AstraZeneca, Merck, and Pfizer.
